Adma Biologics ADMA
NASDAQ ADMA
$9.72 -0.21 (-2.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Adma Biologics (ADMA) Price to Earnings (2024 - 2026)

Updated

Adma Biologics' (ADMA) Price to Earnings stood at 11.16 in Q2 2026, down 46.3% from 20.79 a year earlier and down 11.8% from the prior quarter.

Analysis

Adma Biologics (ADMA) Price to Earnings (2024 - 2026) Analysis & Trends

For FY2025, Adma Biologics' Price to Earnings came in at 29.53, up 43.8% from FY2024.

  • Across earlier years, Price to Earnings came in at 20.53 in FY2024.
  • The Q2 2026 figure is the lowest quarterly Price to Earnings in data going back to Q2 2024.
  • On a year-over-year basis, Price to Earnings rose in 1 of the last five quarters, with an average decline of 39.1%.
  • Per Business Quant, the preceding three quarters came in at 12.66 (Q1 2026), 29.53 (Q4 2025) and 16.68 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Adma Biologics 2.24 Bn 1.81 Bn 86.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.16
Mar 31, 2026 12.66
Dec 31, 2025 29.53
Sep 30, 2025 16.68
Jun 30, 2025 20.79
Mar 31, 2025 22.89
Dec 31, 2024 20.53
Sep 30, 2024 69.35
Jun 30, 2024 74.89
API Access

Adma Biologics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=ADMA&period=max&api_key=YOUR_API_KEY